FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic more...
Xovoltib 30mg Tablet is used in the treatment of non-small cell lung cancer. It is used in the treatment of adult patients who have certain mutations of epidermal growth factor receptor (EGFR). Xovoltib 30mg Tablet should be taken on an empty stomach, but try to have it at the samore...
Xovoltib 40mg Tablet is used in the treatment of non-small cell lung cancer. It is used in the treatment of adult patients who have certain mutations of epidermal growth factor receptor (EGFR). Xovoltib 40mg Tablet should be taken on an empty stomach, but try to have it at the samore...